We evaluated the effects of ganetespib on the expression of proteins associated with RAS/RAF/ERK and PI3K/AKT/mTOR pathways in the MTC cell line (TT) at 48 hours (Figure 3B). This evidence concerns the gene MTOR and medullary thyroid gland carcinoma.